Sandy Cove Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-17,642
Closed -$1.79M 149
2025
Q4
$1.79M Hold
17,642
0.53% 30
2025
Q3
$965K Hold
17,642
0.31% 51
2025
Q2
$937K Hold
17,642
0.34% 47
2025
Q1
$764K Hold
17,642
0.31% 51
2024
Q4
$991K Hold
17,642
0.39% 41
2024
Q3
$1.2M Hold
17,642
0.49% 33
2024
Q2
$745K Hold
17,642
0.33% 52
2024
Q1
$1.22M Hold
17,642
0.56% 29
2023
Q4
$1.31M Hold
17,642
0.67% 27
2023
Q3
$1.2M Hold
17,642
0.7% 25
2023
Q2
$1.66M Sell
17,642
-19,708
-53% -$1.54M 0.94% 20
2023
Q1
$2.53M Hold
37,350
1.83% 16
2022
Q4
$1.85M Sell
37,350
-5,000
-12% -$204K 1.49% 16
2022
Q3
$1.38M Hold
42,350
1.24% 18
2022
Q2
$1.67M Hold
42,350
1.52% 13
2022
Q1
$2.96M Hold
42,350
2.46% 8
2021
Q4
$3.3M Buy
+42,350
New +$3.74M 2.77% 8

Other funds holding EXAS

Sandy Cove Advisors's EXAS Position: Q1 2026 in Review

Sandy Cove Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 17,642 shares — an estimated $1.79M sold.

Sandy Cove Advisors first reported a position in EXAS in Q4 2021 and held it in 17 quarters. The position peaked at $3.3M in Q4 2021. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Sandy Cove Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Sandy Cove Advisors sold 17,642 Exact Sciences shares in Q1 2026, an estimated $1.79M.
  • Sandy Cove Advisors first reported a position in Exact Sciences in Q4 2021 and held it in 17 quarters.
  • Sandy Cove Advisors's Exact Sciences position peaked at $3.3M in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Sandy Cove Advisors's 13F filing for Q1 2026, filed 5 May 2026.